FLUCONAZOLE TABLETS

The Defense Logistics Agency awarded a delivery order under the master contract SPE2DX25D9900 to DMS PHARMACEUTICAL GROUP INC, a small women-owned business with CAGE code 1UNB0, for the procurement of 7.000 bulk tablets of FLUCONAZOLE (NSN 6505013198248, NDC 51407-0425-30) at a total price of $383.95. The order was issued on July 20, 2026, and requires delivery by August 4, 2026, to Fort Bragg, North Carolina, under FOB Destination terms, meaning the contractor bears all transportation risk and cost until the product reaches the destination. The item is a commercial pharmaceutical product, procured using NAICS code 424210, and the award reflects a firm-fixed-price arrangement consistent with a low-dollar, single-line delivery order. Packaging and marking must comply with Department of Defense standards, requiring clear labeling with the NSN, CAGE code 1HT23, and part number, with shipments sent by the fastest traceable means—parcel post is explicitly prohibited. Inspection and acceptance occur at the delivery point, with no formal inspection criteria or quality standards specified beyond adherence to applicable pharmaceutical regulations such as USP or FDA requirements. Payment is to be processed by the Defense Finance and Accounting Service at Columbus, Ohio, under funding identifiers PR 7017565995, DIC A0A, FC Z9, and W91KBP61060282, though no formal invoicing method is stated. The contractor holds socioeconomic certifications as a Small Vantaged Women-Owned and Small Disadvantaged Women-Owned Business, triggering compliance with FAR 52.219-28 and 52.219-14. While the contract includes detailed shipping and labeling instructions and identifies an administrative point of contact at DLA Troop Support Medical Supply Chain, it lacks explicit listings of contract clauses, special requirements, evaluation factors, and formal representations from Section K aside from socioeconomic status. No COR, COTR, or PCO is named, and no additional attachments or clauses beyond the delivery order are documented.